| abstract |
The present invention relates to novel piperidine-dihydrothienopyrimidine sulfoxides of formula I, wherein Ring A is a 6-membered aromatic ring which may optionally comprise one or two nitrogen atoms and wherein R is Cl and wherein R may be located either at the para-, meta- or ortho- position of Ring A, wherein S* is a sulfur atom representing a chiral center, and all pharmaceutically acceptable salts, enantiomers and racemates, hydrates and solvates thereof and the use of such compounds for the treatment of inflammatory or allergic diseases of the respiratory tract such as COPD or asthma. |